| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/12/2011 | CN101584694B Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method |
| 01/12/2011 | CN101560503B Influenza A virus Vero cell adapted strain and application thereof |
| 01/12/2011 | CN101548955B Florfenicol lung targeting microspheres for animals and method for preparing same |
| 01/12/2011 | CN101543589B Compound pharmaceutical composition for curing virus diseases of animals and preparation method thereof |
| 01/12/2011 | CN101507748B External medicine liquor for treating common cold and preparation method thereof |
| 01/12/2011 | CN101456871B Cephalosporin derivative containing mercaptothiazole |
| 01/12/2011 | CN101450927B Benzoic acid derivates containing oxo pyridine substituted propionamido |
| 01/12/2011 | CN101450206B Production method of Escherichia coli K88, K99, 987P cilia subunit oil-emulsion vaccine |
| 01/12/2011 | CN101412717B Carbapenem derivative containing guanidyl alkanoylamino heterocycle |
| 01/12/2011 | CN101406638B Medicament for treating newcastle disease |
| 01/12/2011 | CN101367817B Carbpenem compound containing cyclohexenone formamido group |
| 01/12/2011 | CN101367807B Sulfhydryl pyrrolidine formamido pyridine substituted penem derivant |
| 01/12/2011 | CN101366717B Medicament formulation for treating condyloma acuminata |
| 01/12/2011 | CN101362763B Carbapenem derivates containing sulfhydryl pyrrolidine |
| 01/12/2011 | CN101361810B Traditional Chinese medicine combination for treating virus lower respiratory tract infection and preparation method thereof |
| 01/12/2011 | CN101357920B Penem derivative containing sulfhydryl pyrrolidine formamido triazine |
| 01/12/2011 | CN101351204B Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 01/12/2011 | CN101343271B Penem derivant containing isoxazole alkyl ketone |
| 01/12/2011 | CN101337969B Synthetic method of antibiotic cefixime |
| 01/12/2011 | CN101328179B Sulfhydryl pyrrolidine penem derivates containing oxo aza ring |
| 01/12/2011 | CN101254285B Chinese medicine decoction for curing flat wart |
| 01/12/2011 | CN101185728B Infusion medicine for treating tinea unguium |
| 01/12/2011 | CN101167775B Method for extracting chrysanthemum total flavone |
| 01/12/2011 | CN101137359B Methods of treating ear infections |
| 01/12/2011 | CN101085037B Traditional Chinese medicine preparation for animals and preparation method thereof |
| 01/12/2011 | CN101081863B Lipopolysaccharide conjugated protein and monoclonal antibody and usage |
| 01/12/2011 | CN101050216B Method for synthesizing medication Entecavir of anti hepatitis B |
| 01/12/2011 | CN101020719B Composite angelica polysaccharide and its preparation process and use |
| 01/11/2011 | US7868135 In particular amphomycin or aspartocin derivatives, and compositions of such lipopeptides for use in treating or preventing, for example, primary infection sites, secondary infections arising from a primary disease state, or infections associated with foreign bodies |
| 01/11/2011 | US7868021 Antimicrobial quinolones, their compositions and uses |
| 01/11/2011 | US7868011 Hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
| 01/11/2011 | US7867981 Compositions comprising highly purified amphotericin B |
| 01/11/2011 | US7867509 Fast dissolving orally consumable films |
| 01/11/2011 | US7867502 Genetic engineered polypeptides; useful candidates in a vaccine against tuberculosis (TB) or diagnostic preparation for TB; vaccine; inhibit mycobacterial virulence |
| 01/11/2011 | US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization |
| 01/11/2011 | US7867488 Use of dendritic cells (DCs) expressing interleukin 12 (IL-12) |
| 01/11/2011 | CA2566922C Stable crystal of 4-oxoquinoline compound |
| 01/11/2011 | CA2461623C Water-in-oil emulsions with ethylene oxide groups, compostions, and methods |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2440172C Itraconazole solution |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2378883C Methods of reducing microbial resistance to drugs |
| 01/11/2011 | CA2377479C Compositions and methods for preventing transepithelial transmission of hiv |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/11/2011 | CA2263848C New systems for the regulation of gene expression |
| 01/11/2011 | CA2218764C Vaccine composition containing polyribosylribitol phosphate and method for making same |
| 01/11/2011 | CA2156360C Adhesion receptor antagonists |
| 01/06/2011 | WO2011003100A2 Compositions and methods for diagnosing and/or treating influenza infection |
| 01/06/2011 | WO2011003091A1 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
| 01/06/2011 | WO2011003064A2 Methods of treating neuropathic pain |
| 01/06/2011 | WO2011003018A2 Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof |
| 01/06/2011 | WO2011002836A2 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto |
| 01/06/2011 | WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein |
| 01/06/2011 | WO2011001897A1 Medicinal agent and method for treatment of intractable chronic hepatitis c |
| 01/06/2011 | WO2011001419A1 Covalent inhibition of bacterial quorum sensing |
| 01/06/2011 | WO2011001383A1 Crystalline form of fosamprenavir calcium |
| 01/06/2011 | WO2011001258A1 Compositions, methods, and kits for treating viral and bacterial infections by tocotrienols, tocomonoenols, tocodienols, tocopherols, and their derivates |
| 01/06/2011 | WO2011001208A1 The use of an extract of helichrysum, for the treatment of hiv/aids |
| 01/06/2011 | WO2011000946A1 Gymnemic acids for antifungal applications |
| 01/06/2011 | WO2011000931A1 Biomass made of cyanobacteria having an antimycotic effect |
| 01/06/2011 | WO2011000721A1 Inhibitors of microbial infections |
| 01/06/2011 | WO2011000124A1 Pharmaceutical composition including viable probiotic strains of lactobacillus spp. used for the prevention and recovery of individuals with urinary tract infections and immunocompromised individuals |
| 01/06/2011 | WO2010131118A3 Polymorphs of etravirine and processes for preparation thereof |
| 01/06/2011 | WO2010122571A3 A process for the selective methylation of erythromycin a derivatives. |
| 01/06/2011 | WO2010121225A3 Method of treating disorders associated with protein kinase ck2 activity |
| 01/06/2011 | WO2010097626A3 Methylene blue derivatives |
| 01/06/2011 | WO2010095041A3 Compositions, methods, and kits for treating influenza viral infections |
| 01/06/2011 | WO2010092479A3 Influenza vaccines with reduced amounts of squalene |
| 01/06/2011 | WO2010083477A3 Broad spectrum vaccine against non-typhoidal salmonella |
| 01/06/2011 | WO2010034105A8 Hepatitis c inhibitor compounds |
| 01/06/2011 | US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase |
| 01/06/2011 | US20110004949 Immunoglobulin 1 |
| 01/06/2011 | US20110004948 Immunoglobulin 2 |
| 01/06/2011 | US20110003898 Medical glues for surgery comprising bioactive compounds |
| 01/06/2011 | US20110003889 Membrane fusion inhibitor |
| 01/06/2011 | US20110003888 Hops extraction methods and mixtures |
| 01/06/2011 | US20110003869 Use of Succinate Dehydrogenase Inhibitors for Controlling Sclerotinia ssp. |
| 01/06/2011 | US20110003857 Stabilized, antimicrobially effective composition with a content of bispyridinium alkane |
| 01/06/2011 | US20110003855 Antiviral compounds for the treatment of hcv infection |
| 01/06/2011 | US20110003851 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
| 01/06/2011 | US20110003841 Bioactive composition for the treatment of the hiv/aids, method for manufacturing and using the same |
| 01/06/2011 | US20110003829 Enrofloxacin hexahydrate |
| 01/06/2011 | US20110003827 HIV protease inhibiting compounds |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003803 Compositions and methods for treating ophthalmic, otic, or nasal infections |
| 01/06/2011 | US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 01/06/2011 | US20110003798 Compounds and compositions as kinase inhibitors |
| 01/06/2011 | US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 01/06/2011 | US20110003794 Naphthyridine Integrase Inhibitors |
| 01/06/2011 | US20110003792 Anti-inflammatory agents |
| 01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 01/06/2011 | US20110003789 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 01/06/2011 | US20110003776 Tetrahydropyranonaphthyridines derivatives, pharmaceutical compositions and therapeutic treatment thereof |
| 01/06/2011 | US20110003735 Peptide derivative fusion inhibitors of hiv infection |
| 01/06/2011 | US20110003734 Proteins and polynucleotides of vibrio cholerae |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |